Abiopharma

🔍 Li Xiaodong (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 6,039 shares of Class A ordinary shares at $122.72 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 282,411.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 6,442 shares of Class A ordinary shares at $123.7 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 275,969.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 3,520 shares of Class A ordinary shares at $124.72 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 272,449.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 1,697 shares of Class A ordinary shares at $125.54 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 270,752.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,532 shares of Class A ordinary shares at $126.49 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: false | shares_owned_after: 269,220.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Holds 0 shares of Class A ordinary shares (Direct)
  Date: 2026-08-13 | Code: H | shares_owned_after: 1,021,462.00

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on September 10, 2025.
• F2: Represents the weighted average price of shares sold at prices that ranged from $122.15 to $123.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $123.16 to $124.14.
• F4: Represents the weighted average price of shares sold at prices that ranged from $124.18 to $125.15.
• F5: Represents the weighted average price of shares sold at prices that ranged from $125.16 to $125.99.
• F6: Represents the weighted average price of shares sold at prices that ranged from $126.22 to $126.82.
• REMARKS: This Report includes only the securities that the Reporting Person may be deemed to beneficially own in accordance with Rule 16a-1. This report does not include Class A ordinary shares over which the Reporting Person has no pecuniary interest but has voting power due to irrevocable voting proxies from the respective owners of such shares (including certain directors and employees of the Issuer, certain affiliates of employees of the Issuer, and Garena ESOP Program (PTC) Limited).